Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy.
Adrián FernándezAlfonso Navarro-ZapataAdela EscuderoMatamala NereaBeatriz Ruz-CaracuelIsabel MironesAlicia PernasMarta CoboGema CasadoDiego LanzarotCarlos Rodriguez-AntolinMaría VelaCristina FerrerasCarmen MestreAurora ViejoAlejandra LeivasJoaquin Martinez LopezLucía FernándezAntonio Pérez-MartínezPublished in: Cancers (2021)
GMP-grade NK cells for clinical use can be obtained by using different starting cells and aAPC.